Comparative study of the expression of cellular cycle proteins in cervical intraepithelial lesions

Pathology Research and Practice

Volumn 202, Issue 10, 2006, Pages 731-737

  Queiroz, Conceição ^a   Silva, Tânia Correia ^b   Alves, Venâncio A F ^d   Villa, Luisa L ^c   Costa, Maria Cecília ^c   Travassos, Ana Gabriela ^a   Filho, José Bouzas Araújo ^a   Studart, Eduardo ^a   Cheto, Tatiana ^b   de Freitas, Luiz Antonio R ^a,b  

^a Medical School   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cervical neoplasia; Cyclin D1; Ki67; P16^{INK4a< sup>; p53}

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P16INK4A; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PROTEIN EXPRESSION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

EID: 33748654444     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.07.003     Document Type: Article

References (36)

1. Alani R.M., and Munger K. Human papillomaviruses and associated malignancies. J. Clin. Oncol. 16 (1998) 330-337
2. Al-Saleh W., Delvenne P., Greimers R., Fuedman V., Doyen J., and Boniver J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with histologic grade and human papillomavirus type. Am. J. Clin. Pathol. 104 (1995) 154-160
3. Bae D.S., Cho S.B., Kim Y.J., Whang J.D., Song S.Y., Park C.S., Kim D.S., and Lee J.H. Aberrant expression of Cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol. Oncol. 81 (2001) 341-347
4. Bosch F.X., Lorincz A., Muñoz N., Meijer C.J.L.M., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
5. Cooper K., Herrington C.S., Evans M.F., Gatter K.C., and James O.D. P53 antigen in cervical condylomata, intraepithelial neoplasia and carcinoma: Relationship to HPV infection and integration. J. Pathol. 171 (1993) 27-34
6. Dimitrakakis C., Kymionis G., Diakomanolis E., Papaspyrou I., Rodolakis A., Arzimanoglou I., Leandros E., and Michalas S. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol. Oncol. 77 (2000) 129-136
7. Dyson N., Howley P.M., Munger K., and Harlow E. The human papillomavirus-16E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989) 934-937
8. B. Escofier, J. Pagès, Análisis factoriales simples y múltiples objetivos, métodos e interpretación, Bilbao: Ed. Universidad Del Pais Vasco, Bilbao, 1992, p. 285.
9. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Désy M., and Rohan T.E. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from high-risk area for cervical cancer. J. Infect. Dis. 180 (1999) 1415-1423
10. Gerdes J., Schwab U., Lemke H., and Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31 (1983) 13-20
11. Gerdes J., Li L., Schlwter D.M., Wohlenberg G., Gerlach C., Stahmer I., Kloth S., Brandt E., and Flad H.D. Immunohistochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Clin. Pathol. 138 (1991) 867-873
12. Hengstermann A., Linares L.K., Ciechanover A., Whitaker N.J., and Sheffner M. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer. Proc. Natl. Acad. Sci. USA 98 (2001) 1218-1223
13. Ho G.Y., Burk R.D., Kein S., Kadish A.S., Chang C.G., Palan P., Basu J., Tachezy R., Lewis R., and Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87 (1995) 1365-1371
14. Keating J.T., Cviko A., Riethdorf S., Riethdorf L., Quade B.J., Sun D., Duensing S., Sheets E.E., Munger K., and Crum C.P. Ki67, Cyclin E and p16INK4a are complementary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am. J. Surg. Pathol. 25 (2001) 884-891
15. Klaes R., Friedrick T., Spitkovsky D., Ridder R., Rudy W., Petry U., Dallenbach-Hellweg G., Schimidt D., and von Knebel Doeberitz M. Overexpression of p16 INK4a as a specific marker for dysplastis and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 (2001) 276-284
16. Klaes R., Dener A., Friedrich T., Rudiger R., Herringtin S., Jenkins D., Kurman R., Schmidt D., Stoler M., and von Knebel Doeberitz M. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intra epithelial neoplasia. Am. J. Surg. Pathol. 26 (2002) 1389-1399
17. Konishi I., Fujii S., Hirofumi N., Nanbu Y., Iwai T., and Mori T. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki67 antigen and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer 68 (1991) 1340-1350
18. Kruse A.-J., Skaland I., Jassen E.A., Buhr-Wildhagen S., Klos J., Arends M.J., and Baak J.P.A. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability. Int. J. Gynecol. Pathol. 23 (2004) 100-109
19. Lee J.H., Kang Y.S., Koh J.W., Kim B.G., Lee E.D., Park K.B., and Seo Y.L. p53 gene mutation is rare in human cervical carcinomas with positive HPV sequences. Int. J. Gynecol. Cancer 4 (1994) 371-378
20. Lyall H., and Duncan I.D. Innacuracy of cytologic diagnosis in high grade squamous intraepithelial lesions (CIN3). Acta Cytol. 39 (1995) 50-54
21. Neggri G., Vitadello F., Romano F., Kasal A., Rivasi F., Girlano S., Mian C., and Ergarter-Vigl E. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of cervix uteri. Virchows Arch. 445 (2004) 616-620
22. Park C.S., Joo I.S., Song S.Y., Kim D.S., Bae D.S., and Lee J.H. An Immunohistochemical analysis of heat shock protein 70, p53 and estrogen status in carcinoma of the uterine cervix. Gynecol. Oncol. 74 (1999) 53-60
23. Queiroz C., Silva T.C.S., Alves V.A.F., Villa L.L., Costa M.C., Travassos A.G., Araújo-Filho J.B., Studart E., Cheto T., and Freitas L.A.R. P16INK4a expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Pathol. Res. Pract. 202 (2006) 77-83
24. Resnick M., Lester S., Tate J.E., Sheets E.E., Sparks C., and Crum C.P. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intrtaepithelial neoplasia. Hum. Pathol. 27 (1996) 234-239
25. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Immunohistochemical overpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol. Int. 48 (1998) 580-585
26. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncongenic potential in cervical and genital lesions. Am. J. Pathol. 153 (1998) 1741-1748
27. Schlecht N.F., Trevisan A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., and Franco E.L. Viral load as a predictor of cervical intraepithelial neoplasia. Int. J. Cancer 103 (2003) 519-524
28. Serrano M., Haanon G.J., and Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
29. Sherr C.J. The INK4a/ARF network in tumor suppressor and its relatives. Natl. Rev. Mol. Cell Biol. 1 (2001) 731-737
30. Skomedal H., Kristensen G.B., Lee A.K., and Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM 2, p21, p27, cdk4, Cyclin D1, RB and EGFR in cervical carcinomas. Gynecol. Oncol. 73 (1999) 223-228
31. Tringler B., Gup C.J., Singh M., Groshong S., Shroyer L., Heinz D.E., and Shroyer K.R. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum. Pathol. 35 (2004) 689-696
32. Vassalo J., Derchain S.F.M., Pinto G.A., Martinez E., Sÿrjanen K.J., and Andrade L.A.L. High risk HPV and p53 protein expression in cervical intraepithelial neoplasia. Int. J. Gynecol. Obstet. 71 (2000) 45-48
33. Walboomers J.M., Jacobs M.V., and Manos M.M. Human papillomavirus is a necessary cause of invasive cervical cancer worldwilde. J. Pathol. 189 (1999) 12-19
34. Wang J.-L., Zheng B.-Y., Li X.-D., Angström T., Lindström M.S., and Wallin K.-L. Predictive significance of the alterations of p16INK4a, p14ARF, p53 and Proliferation Cell Nuclear Antigen expression in the progression of cervical cancer. Clin. Cancer Res. 10 (2004) 2407-2414
35. Wang H.L., and Lu D.W. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am. J. Surg. Pathol. 28 (2004) 901-908
36. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim. Biophys. Acta 1288 (1996) 55-78